Genomics

Dataset Information

0

Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing


ABSTRACT: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing

PROVIDER: PRJNA1168595 | ENA |

REPOSITORIES: ENA

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-01-21 | GSE154524 | GEO
| PRJNA1168596 | ENA
| PRJNA553269 | ENA
| PRJNA553270 | ENA
2021-07-07 | PXD021726 | Pride
2013-12-15 | E-GEOD-53325 | biostudies-arrayexpress
2016-04-30 | E-MTAB-3770 | biostudies-arrayexpress
2015-05-12 | E-GEOD-55399 | biostudies-arrayexpress
| PRJEB30310 | ENA
2015-05-12 | GSE55399 | GEO